Nipple Inflammation: An Unusual Adverse Effect From Vemurafenib, a V600E BRAF Inhibitor During Off-Lable Treatment for Anaplastic Thyroid Carcinoma

Enliven: Clinical Dermatology
doi 10.18650/2379-5832.22004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Enliven Archive

Related search

Salvage Pembrolizumab Added to Kinase Inhibitor Therapy for the Treatment of Anaplastic Thyroid Carcinoma

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Anaplastic Thyroid Carcinoma: Review of Treatment Protocols

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2018English

Anaplastic Thyroid Carcinoma

2020English

Thyroid Tuberculosis Mimicking an Anaplastic Carcinoma: A Rare Presentation

Global Journal of Otolaryngology
2017English

Thyroid: Anaplastic (Undifferentiated) Carcinoma

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Anaplastic Thyroid Cancer Evolved From Papillary Carcinoma

Archives of Otolaryngology–Head & Neck Surgery
2003English

Unusual Manifestation of Anaplastic Thyroid Cancer

Acta medica (Hradec Kralove)
Medicine
2008English

Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma

Asian Pacific Journal of Cancer Prevention
2019English

Radiotherapy in Anaplastic Thyroid Carcinoma: An Australian Experience

Journal of Medical Imaging and Radiation Oncology
OncologyRadiologyNuclear MedicineImaging
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy